Real-world studies assess treatment effectiveness and patient experience beyond clinical trial settings, considering broader patient populations. Clinical trials have stricter enrollment criteria, ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

When people hear the term “clinical trial,” they often imagine someone with a serious illness, desperate for a last-resort treatment, being poked and prodded in a lab. These images are persistent, but ...

When you think of clinical trials for cancer, testing a new medication may come to mind. But drugs aren’t the only thing these trials investigate. There’s a growing world of nonpharmaceutical clinical ...

The National Institutes of Health will no longer categorize basic experimental studies involving humans (BESH) as clinical trials, according to a Jan. 29 announcement from the agency. BESH ...

Neuralink’s first brain implant in a human patient took place in January 2024, but the details of what the company’s clinical trial actually requires of participants, regulators, and the company ...

A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

You might know the term “placebo,” even if you’re not entirely sure what it is. In clinical trials, a placebo is an inactive substance or treatment that looks the same and is given the same way as an ...

Clinical trials can vary in length depending on several factors. Here's what you need to know about how long clinical trials last.

START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.

However, in the glass box approach, the raw and timestamped data (such as physiological signals like ECG, temperature, or ...